GnRH I and its receptors have been demonstrated in the ovaries of various vertebrates, but their physiological significance in reproductive cascade is fragmentary. Bradykinin is a potent GnRH stimulator in the hypothalamus. In the present study, the presence of GnRH I and its receptor, and bradykinin and its receptor in the ovaries of non-mammalian vertebrates were investigated to understand their physiological significance. GnRH I immunoreactivity in the ovaries of fish, frog, reptile and bird were mainly found in the oocyte of early growing follicles and granulosa cells and theca cells of previtellogenic follicles. Vitellogenic follicles showed mild GnRH immunoreactivity. GnRH I-receptor and bradykinin were localized in the same cell types of the ovaries of these vertebrates. The presence of GnRH I, GnRH I-receptor and bradykinin in the ovaries of these vertebrates was confirmed by immunoblotting. The presence of GnRH I mRNA was demonstrated in the ovary of vertebrates using RT-PCR. The ovaries of reptiles and birds showed significantly higher intensity of immunoreactivity for GnRH I-receptor as compared with the fish and amphibian. This may have a correlation with the higher yolk content in the ovary of reptile and bird. These results suggest the possibility of GnRH I and bradykinin as important regulators of follicular development and vitellogenesis in the vertebrate ovary. 
Introduction
The hypothalamic gonadotrophin-releasing hormone (GnRH) is the key regulator of reproductive functions in all the vertebrate species. The major function of this decapeptide is to modulate the synthesis and release of gonadotrophins from the pituitary. GnRH binds to its receptor localized on the pituitary gonadotrophs, where it is involved in the synthesis and release of gonadotrophins. The gonadotrophins in turn stimulate hormone and gamete production by the testes and ovaries. Now, it is well documented that GnRH is not exclusively synthesized in the hypothalamus. Several in vivo (Sakamoto et al. 1993 , Srivastava et al. 1995 , Raga et al. 1998 and in vitro studies have shown that GnRH ligands and their agonists can have various extrahypothalamic functions (Ortmann & Diedrich 1999) . A number of studies have shown that GnRH and its receptor are also expressed in some peripheral reproductive tissues including mammary gland, ovary, endometrium and placenta, suggesting that the peptide hormone may have other extrapituitary functions in addition to its role as a GnRH (Harrison et al. 2004) .
The intra-ovarian production of GnRH has been reinforced by demonstration of ovarian compounds with GnRH-like activity (Aten et al. 1986 (Aten et al. , 1987 and ovarian GnRH gene expression (Peng et al. 1994) . The presence of GnRH-binding sites in ovarian tissues suggests that GnRH acts through receptor-mediated processes in the ovary (Schirman-Hildesheim et al. 2005) . In the mammalian ovary, GnRH I and its type-I receptors (GnRH I-receptor) are localized in the granulosa cells (GCs; Jones & Hsueh 1980 , Reeves et al. 1982 , Kang et al. 2003 and luteal cells (Clayton et al. 1979 , Bauer-Dantoin & Jameson 1995 , suggesting that this peptide may have autocrine and/or paracrine regulatory function in the ovary. Importantly, unlike the pituitary, ovarian GnRH I-receptors are activated by locally produced GnRH I, because the half-life of this peptide is only a few minutes, and they are found in the peripheral circulation in undetectable concentrations. A myriad of functions have been attributed to GnRH in the mammalian ovary (for review, Leung et al. 2003) , such as a role in oocyte maturation (Hillensjo & LeMaire 1980) , follicular selection and apoptosis, steroidogenesis and effects on the corpus luteum (Srivastava et al. 1995 , Kang et al. 2003 . The expression of GnRH in immature gonads suggests that the role of GnRH is considerably broader than that understood presently. The factor(s) regulating GnRH I synthesis and secretion in the ovary remains poorly understood. Bradykinin emerged as a potent GnRH stimulator from hypothalamic fragment and bradykinin has been shown to localize in the hypothalamic area (Shi et al. 1998 (Shi et al. , 1999 . The fact that bradykinin neurons in the hypothalamus play a physiological role in the control of GnRH and luteinizing hormone (LH) release is supported by the finding that central administration of the bradykinin B 2 receptor antagonist into the third cerebral ventricle blocked the steroid-induced LH surge in the ovariectomized adult female rat. This suggests that bradykinin acts directly on GnRH neurons through a mechanism involving mediation by the bradykinin B 2 receptor. It has already been reported that kinin-producing activity increases during ovulation (Smith & Perks 1983 , Espey et al. 1989 , Gao et al. 1992 . In a study, Kihara et al. (2000) showed the presence of a component of bradykinin and bradykinin-producing system in the porcine ovarian follicle, suggesting its role in early follicular development and ovulation. It has been demonstrated that bradykinin induces ovulation in perfused rabbit ovaries (Yoshimura et al. 1988 , Hellberg et al. 1991 , potentiates the action of LH (Brännström & Hellberg 1989 ) and a physiological role of bradykinin in the LH surge was also implicated (Shi et al. 1998) . Whether bradykinin is also involved in the regulation of ovarian GnRH I synthesis and secretion requires investigation. Therefore, in the present study, the localization and distribution of GnRH I and bradykinin and their receptors were investigated in the ovary of non-mammalian vertebrates (fish, amphibia, reptiles and aves).
Materials and Methods

Sample collection
All experiments were conducted in accordance with the principals and procedures approved by the Departmental Research Committee at Banaras Hindu University, Varanasi, India. Adult females, four to six in number and belonging to different vertebrate classes, were captured in their reproductively active phase from Varanasi and adjacent areas; for example, fish, Heteropneustes fossilis (between February and September); amphibia, Rana tigrina (between June and July); reptile, Calotes versicolor (between March and September) and aves, Estrilda amandava (between August and September). Animals were killed by decapitation as soon as they were taken to the laboratory. Ovaries were dissected out. One side of the ovary from each animal was cleaned and kept either frozen at K20 8C for immunoblot analysis or in the RNA later (Ambion, Austin, TX, USA) at K20 8C for RNA extraction and real-time PCR analysis respectively. The ovary from the other side was used for immunohistochemistry. Each ovary was fixed in Bouin's fluid for 24 h, dehydrated in ethanol, cleared in xylene, embedded in paraffin wax and serially sectioned at 6 mm.
Classification of ovarian follicles/oocytes of nonmammalian vertebrates
The ovarian follicles/oocytes are classified into the following types based on their size, presence of vacuoles in the periphery and amount and types of yolk accumulation: a) primordial/primary follicle -oocyte small with translucent cytoplasm, GCs and theca cells not present; b) secondary previtellogenic follicleoocyte medium-sized with opaque cytoplasm and showing varying amount of peripheral vacuoles, GCs present; c) secondary vitellogenic follicle -mediumsized oocytes with opaque cytoplasm containing pigmented granules and both granulosa and theca cells present and d) tertiary fully grown follicle -large oocytes with cytoplasm containing large yolk platelets, several layers of granulosa and thecal cells (TCs) present.
RNA purification
The total RNA from the ovary was isolated using Agilent total RNA Isolation Mini kit (Product no. 5185-6000; Agilent Technologies Inc., Wilmington, DE, USA). The purity and concentration of the isolated total RNA was checked in Agilent 2100 Bioanalyzer (Functional Genomics Core Facility, Morehouse School of Medicine, Atlanta, GA, USA).
RT reaction
The total RNA from each ovarian sample (2 mg) was converted to cDNA by RT reaction using RT Taqman Kit (Part no: 808-0234; Applied Biosystem Inc., Foster City, CA, USA). Hypothalamic RNA sample was used as control and reverse transcribed along with the ovarian RNA. The reaction protocol was followed according to the manufacturer's instructions. The reaction mixture contained 1!RT buffer, 5.5 mM MgCl 2 , 500 mM/dNTP, 2.5 mM random hexamer, 0.4 U/ml RNase inhibitor and 3.125 U/ml MultiScribe Reverse Transcriptase in final volume of 100 ml. RT reactions were carried out in a DNA Thermal cycler using a program with the following reaction condition: activation of enzyme at 25 8C for 10 min, cDNA formation at 48 8C for 37 min and finally incubation at 95 8C for 5 min to inactivate the enzyme and denature RNA-DNA hybrid. The quality of ssDNA and RNA was checked spectrophotometrically by taking absorbance at 260 and 280 nm.
Relative real-time PCR
Sequence of GnRH I mRNA (rat and human) were obtained from the GenBank database of the National Center for Biotechnology Information of NIH, USA (http://www.ncbi.nlm.nih.gov/Genbank/index.html). Using OligoPerfect Designer software (Invitrogen) primer and probe sequences were selected to optimally hybridize and amplify target cDNA sequence for realtime PCR assay. To avoid amplification of contamination of genomic DNA, primers specific for both GnRH I and 18S (housekeeping gene) were designed for crossexon/intron boundaries. The primer sequences of GnRH I and 18S are described in Table 1 .
The real-time PCR assay was performed in an iCycler iQ Real time PCR detection system (Bio-Rad Laboratories) using cDNA (750 or 1125 ng) for each reaction. Each gene expression was assessed in a separate PCR and each reaction mixture consisted of 2 ml left and right primers (0.35 nM/ml concentration) of GnRH I and 18S respectively, 10 ml of 2! quantiTech SYBERGreen PCR buffer, dNTP mix including dUTP, fluorescent dyes like SYBERGreen1 and ROX and 5 mM MgCl 2 procured from Qiagen and DNase-RNase-free water to make a total volume of 20 ml. Samples were amplified with a precycling hold of 95 8C for 15 min followed by 50 cycles of denaturation at 94 8C for 15 s, annealing at 54 8C for 30 s and extension at 72 8C for 30 s. The reaction was terminated at 72 8C for 5 min and cooled to 4 8C. Quantification results were expressed in terms of cycle threshold value (Table 2) .
Antibodies
All the antisera used in this study were obtained from commercial sources (Table 3) . GnRH I antibody used in this study was highly specific and showed only 6.6% cross-reactivity with lamprey GnRH, but very minimal cross-reactivity with other GnRHs including chicken GnRH (GnRH II) and salmon GnRH (GnRH III) based on assessments by the manufacturer using sensitive RIA applications. A highly specific GnRH I-receptor antibody used was an MAB against 1-29 amino acid epitope at the amino terminus of human GnRH I-receptor.
Immunohistochemistry
Ovarian sections were processed through a standard protocol of immunohistochemistry (Table 3) . After deparaffinization and rehydration, endogenous peroxidase was quenched with 0.3% H 2 O 2 , equilibrated in 0.05 mol/l Tris-Cl-0.15 mol/l NaCl (TBS, pH 7.3). Background blocking was performed with normal horse serum. The tissue sections were incubated for 1 h at room temperature with rabbit polyclonal antibody against human GnRH I (GnRH I, Peninsula Lab Inc., San Carlos, CA, USA) diluted to 1:1500, GnRH I-receptor (Santacruz Biotechnology Inc., Santa Cruz, CA, USA) antibody diluted to 1:25 and bradykinin (Peninsula Lab Inc.) antibody diluted to 1:2000 and bradykinin B 2 receptor (BD Transduction Laboratories, San Jose, CA, USA) antibody diluted to 1:25 in TBS. The detection system used was ABC staining kit from Vector Laboratories, Novo Castra (UK). The peroxidase activity was revealed in 0.03% 3,3 0 -diaminobenzidine tetradihydrochloride (DAB; Sigma) in 0.01 M Tris-Cl (pH 7.6) and 0.1% H 2 O 2 . Nucleus was counterstained with Elrich's hematoxylin. For preabsorbed control, the primary antibodies (in the same dilution as used for localization) were incubated with the pure antigen in the final concentration of 20 ng/100 ml overnight at 4 8C. 
Slot blot
Protein was extracted as described elsewhere (Chanda et al. 2004) . Equal amount of protein as determined by Folin's method was equated with PBS. Ten micrograms of this sample were loaded on nitrocellulose (NC) membrane using Millipore slot blot apparatus. Nonspecific sites were blocked with 5% non-fat-dried milk in TBS, 0.02% Tween 20. The membrane was then incubated with rabbit anti-human GnRH I antibody (1:2000) or rabbit anti-human bradykinin antibody (1:2000). Immunodetection was performed with antirabbit immunoglobulin G horseradish peroxidase (IgG-HRP) conjugated (1:1000). Finally, membrane was developed with ECL. Validation of the slot blot assay was performed using serially diluted ovarian protein samples ranging between 2 and 20 mg/ml. The intensity of the protein bands of the slot blot was quantified using densitometry. The graph plotted between the amounts of protein loaded and the intensity of the protein band showed strong correlation (rZ0.98; Fig. 1 ). The intraassay coefficient of variation was !7.5% and the sensitivity of the blot was w2 mg/ml.
Western blot
Protein was extracted as described elsewhere (Chanda et al. 2004) . Equal amount of proteins (300 mg) as determined by Folin's method was loaded on SDS-PAGE for electrophoresis. The protein was transferred on nitrocellulose membrane (Sigma). Non-specific sites were blocked with 5% non-fat-dried milk in TBS, 0.02% Tween 20. The membrane was then incubated with mouse anti-human GnRH I-receptor antibody (1:250) or mouse anti-human bradykinin receptor antibody (1:250). Immunodetection was performed with anti-mouse IgG-HRP conjugated (1:1000). Finally, membrane was developed with DAB. Blot was repeated thrice for each protein.
Densitometry
The densitometric analysis was performed by scanning and subsequently quantifying the blots using a computerassisted image-analysis system (AlphaEaseFC software, Alpha Innotech Corporation, San Leandro, CA, USA). The system was calibrated to have constant parameter for light (intensity and area of light beam) throughout the experiment. Absorbance was expressed as integrated density value. Each measurement was repeated twice. The data were presented as the mean of the integrity density valueGS.E.M. of three blots of each peptide.
Results
Presence of GnRH I mRNA in the ovaries of different species of non-mammalian vertebrate
The mRNA for GnRH I has been found using primers for rat and human GnRH gene in the ovaries of various vertebrates and their relative Ct values in comparison with mammalian hypothalamus (Table 1) .
Distribution of GnRH I and GnRH I-receptor in the ovaries of different species of non-mammalian vertebrate
Ovarian sections of fish, frog, reptile and bird during their reproductively active period were immunostained for GnRH I and GnRH I-receptor to demonstrate their localization and the results are summarized in Tables  4-7 and Figs 2-5. The primordial and primary follicles generally showed no immunoreactivity in all the vertebrate species. GnRH I immunoreactivity appeared first in the oocyte of early previtellogenic secondary follicles. GnRH I immunoreactivity was much stronger in the oocytes of fish and frog than in the oocytes of reptile and bird. In ovarian follicles of bird and reptile, GnRH I immunoreactivity is localized mainly in GCs and TCs, whereas oocyte shows mild or no immunoreactivity. The intensity of GnRH I immunoreactivity increases as the follicles increase in size and immunoreactivity localized in the periphery of oocytes, GCs and TCs. The maximum intensity of GnRH I immunoreactivity was found in the early vitellogenic follicles. The GnRH I immunoreactivity declined to mild or no staining in the fully grown vitellogenic tertiary follicles. Atretic follicles also showed no immunoreactivity. In the ovary of reptile and bird, GnRH I immunoreactivity was also seen in the interstitial cells. The pattern of GnRH I-receptor immunoreactivity in the ovaries of fish, frog, reptile and bird was nearly the same as described for GnRH I. The maximum GnRH I-receptor immunoreactivity was found in the previtellogenic and vitellogenic secondary follicles. Immunoreactivity was seen in the oocytes and 
Scores for intensity of immunoreactivity are as follows: K, absence of immunoreactivity; C, mild; CC, moderate; CCC, intense; *, absence of the cells in the section. 
Scores for intensity of immunoreactivity are as follows: K, absence of immunoreactivity; C, mild; CC, moderate; CCC, intense; *, absence of the cells in the section. GCs in fish and frog, whereas in the GCs and TCs in the reptile and bird follicles.
Distribution of bradykinin and bradykinin B 2 receptor (BK-R) in the ovaries of different species of nonmammalian vertebrates
Ovarian sections of fish, frog, reptile and bird during their reproductively active period were immunostained for bradykinin and BK-R to demonstrate their localization and results are summarized in Tables 4-7 and Figs 2-5.
The primordial and primary follicles generally showed no immunoreactivity for bradykinin and BK-R in all the vertebrate species. Moderate to intense bradykinin immunoreactivity was noticed in the oocyte, GCs and TCs of previtellogenic and vitellogenic secondary follicles, whereas fully grown vitellogenic tertiary follicles showed mild to no immunoreactivity in the ovaries of fish, frog, reptile and bird. A strong immunoreactivity was also noticed in the interstitial cells of the reptile and bird ovaries. The pattern of BK-R immunoreactivity in the ovaries of fish, frog, reptile and bird was nearly the same as 
Scores for intensity of immunoreactivity are as follows: K, absence of immunoreactivity; C, mild; CC, moderate; CCC, intense; *, absence of the cells in the section.
described for bradykinin. The maximum BK-R immunoreactivity was found in the previtellogenic and vitellogenic secondary follicles. Immunoreactivity was seen in the oocytes and GCs in fish and frog, whereas in the GCs and TCs in the reptile and bird follicles.
Relative concentration of GnRH I, bradykinin and their receptors in the ovaries of different species of nonmammalian vertebrates
GnRH I and bradykinin in the ovary and hypothalamus of fish, frog, reptile and bird were detected by slot blot. The variations in the intensity of immunostaining of the slot blots representing the concentration of GnRH I/bradykinin were measured by densitometry and results are shown in Figs 6 and 7. The densitometric analysis of GnRH I and bradykinin slot blots showed marked variation in the immunoreactivity between the ovaries of different vertebrate species. The ovary of the reptile showed distinctly higher intensity of GnRH I and bradykinin immunostaining when compared with the ovaries of other vertebrates. The hypothalamus of frog showed a distinctly higher intensity of GnRH I immunostaining when compared with the hypothalmus of other vertebrates. Western blot analysis of GnRH I-receptor in the ovaries of fish, frog, reptile and bird showed a single immunoreactive band at 62 kDa. Densitometric analysis of western blot of GnRH I-receptor in the ovaries of different vertebrate species showed a marked variation. The ovaries of reptile and bird showed significantly higher intensity of immunoreactivity of GnRH I-receptor when compared with the ovaries of fish and frog as well as with the pituitary of rat.
Western blot analysis of BK-R in the ovary of fish, frog, reptile and bird showed two immunoreactive bands at 42 and 44 kDa respectively. Densitometric analysis of western blot of BK-R in the ovaries of different vertebrate species showed a marked variation with the highest immunoreactivity found in the bird ovary. 
Discussion
The present immunocytochemical study demonstrates, for the first time, the distribution of GnRH I, bradykinin and their receptors in the ovaries of fish, frog, reptile and bird during the reproductively active phase. The presence of GnRH I was confirmed by the demonstration of its mRNA in the ovaries of fish, frog, reptile and bird using mammalian primers. The presence of GnRH I, bradykinin and their receptors was further confirmed by slot/western blot. Bradykinin has been suggested to be a potent stimulator of GnRH I release in the hypothalamus (Shi et al. 1998) ; however, whether bradykinin causes release of GnRH I in the ovary is not known. The presence of bradykinin together with GnRH I in the ovarian cell suggests the possibility of bradykinin as a regulator of GnRH release. The presence of complete GnRH I system with the ligand peptide and mRNA, and receptor and its regulator existing within the ovaries of fish to bird thus support an intra-ovarian role for GnRH I peptide in the vertebrate ovaries, which appears to be conserved during evolution.
GnRH has often been demonstrated in the ovary of several mammalian as well as non-mammalian vertebrates using RT-PCR techniques without functional assays of protein expression and localization. In nonmammalian vertebrates, GnRH I peptide has been isolated and biochemically characterized from the ovary of goldfish (Pati & Habibi 1998 , Yu et al. 1998 . In the ovary of the frog, Rana esculenta, GnRH-like substance has been identified using high performance liquid chromatography followed by RIA (Battisti et al. 1994) , whereas GnRH immunoreactivity using cGnRH II antiserum is observed in the ovary of newt, Triturus carnifex (Battisti et al. 1997) . However, immunoreactive GnRH could not be detected in the ovary of lungfish, Protopterus annectens (King et al. 1995) . In the present study, the presence of both mRNA and peptide for GnRH I are demonstrated in the ovary of vertebrate species of fish, amphibia, reptilia and birds. The presence of mRNA is shown by RT-PCR, whereas GnRH I peptide is demonstrated by immunocytochemistry (ICC) and slot blot using human GnRH I antiserum in the ovaries of vertebrate species of fish, amphibia, reptilia and bird. Within the ovary, GnRH I is localized mainly in the growing follicles. In previtellogenic follicles, mild GnRH I immunoreactivity is mainly found in the outer margin of oocytes. In the vitellogenic follicles, GnRH I immunoreactivity is observed in the GCs and TCs. The presence of GnRH I and its receptors in the GCs and TCs suggest that GnRH I exerts its action in an autocrine/ paracrine manner (Peng et al. 1994) . GnRH is an intraovarian regulatory factor supported by localization of GnRH I and its receptors in the ovarian tissues as well as by previous observations on the direct effects of this decapeptide on folliculogenesis and steroidogenesis (Stojilkovic et al. 1994 , Andreu et al. 1998 , Kang et al. 2000 , Irusta et al. 2003 . The shift in immunoreactivity from oocyte to GCs and TCs as follicles grow is intriguing and needs further investigation. The present study also showed an increase in the GnRH I immunoreactivity in the GCs and TCs as the follicles grow and the absence of GnRH I immunoreactivity in atretic follicles. These observations suggest that GnRH I promotes follicular development in the vertebrate ovary. This is consistent with a recent study suggesting the proliferative role of GnRH in the pituitary gonadotropes (Miles et al. 2004) . The in situ studies on the rat ovary have indicated the presence of the GnRH I-receptor mRNA in the GCs of the primary, secondary and tertiary follicles (Kogo et al. 1999) . The presence of GnRH-like peptides was first identified in luteinized rat ovaries (Aten et al. 1986) , and the expression of GnRH has been localized to GCs of the follicle (Clayton et al. 1992) . The production of GnRH by ovarian cell types is now well demonstrated in many vertebrate species. It has recently been shown that oocytes of the gilthead sea bream (Wong & Zohar 2004) , rat and mouse (Schirman-Hildesheim et al. 2005) produce and release gonadotrophin together with GnRH. The available data suggest that ovarian GnRH receptors are located on oocytes or GCs (Uzbekova et al. 2002) . A further in vitro study showed that the treatment with GnRH analogue enhanced, whereas the treatment with GnRH antagonist reduced the gonadotrophin release from the oocyte of the Gilthead Sea bream (Wong & Zohar 2004) . Collectively, these observations support the intriguing possibility that ovarian GnRH-gonadotrophin axis may be involved in bidirectional communication between oocytes and their companion somatic cells during follicular and/or oocyte development.
The results of this study clearly demonstrate the presence of GnRH I-receptor in the ovaries of all the vertebrate species (fish, frog, reptile and bird). Among vertebrates, the presence of GnRH I-receptor has previously been demonstrated mainly in the ovaries of several species of fishes: African catfish, Clarias gariepinus (Habibi et al. 1994) , sea bream, Sparus aurata (Nabissi et al. 1997) , goldfish, Carassius auratus (Pati & Habibi 1998 ) and a teleost, Fugu rubripes (Moncaut et al. 2005) . The presence of GnRH I-receptor in the vertebrate ovary suggests that GnRH I acts through a receptormediated process (Schirman-Hildesheim et al. 2005) . Unlike the pituitary GnRH I-receptor, ovarian receptors are most likely activated by locally produced GnRH I, since this peptide is not found in detectable amounts in the peripheral circulation. Within the ovary, GnRH I-receptor immunoreactivity was mainly found in the GCs and oocytes, which are the sites of GnRH immunolocalization. This is in agreement with a study on the rat ovary, where both GnRH I and GnRH I-receptor mRNA are demonstrated to be present in the GCs of the growing follicles, suggesting the involvement of GnRH I in follicular growth and selection (Kogo et al. 1999) . Similarly in mammalian testis, GnRH I is produced by the Sertoli cells, whereas GnRH I-receptor is found on the Leydig cells (Bahk et al. 1995) . These observations suggest that GnRH receptors are closely located to the site of GnRH synthesis in the ovary as well as in other extrahypothalamic loci. These findings suggest the co-evolution of GnRH I/GnRH I-receptor together as a coordinated functional unit. Since GnRH receptors are localized in multiple sites in the ovary, it can be suggested that GnRH receptor might be involved in the control of various ovarian functions. In addition to the direct effects of the GnRH-receptor in activating intracellular signalling, recent studies have suggested a cross-talk of GnRH-receptor with some growth factor receptors such as epidermal growth factor (EGF)-receptor (Shah et al. 2003) . It is now well known that various paracrine and autocrine factors functionally interact with one another in a highly coordinated fashion . Thus, the actions of GnRH within the ovary are diverse and need further detailed investigation. In the present study, GnRH I and GnRH I-receptor concentrations were compared in the ovaries of various vertebrate species (fish, frog, reptile and bird). The result showed relatively higher intensities of GnRH I and GnRH I-receptor in the ovaries of the reptile, C. versicolor, when compared with the other vertebrate species. Interestingly, the intensities of GnRH I-receptor in the ovary of the reptile were found significantly higher than the intensities of GnRH I-receptor in the rat pituitary lysate. This finding suggests that the significance of GnRH I in the ovary is no less than its classical role in the pituitary to stimulate the synthesis and release of gonadotrophins. The reason for the higher GnRH I/GnRH I-receptor concentration in the ovary of the reptile is not known, it may be correlated with the higher yolk accumulation in their ovary. The GnRH I may have other important functions in the oocyte of the reptiles, which require further detailed investigation.
Despite the fact that the roles of bradykinin in the mammalian ovary are well recognized (Kihara et al. 2000) , little is known about the presence of peptide in the ovary of non-mammalian vertebrates. The present study demonstrates for the first time the presence of bradykinin as well as BK-R using immunocytochemistry and western blotting in the ovaries of different vertebrate species (fish, frog, reptile and bird). In all the vertebrate Figure 6 Slot blot for GnRH I and western blot for GnRH I-receptor. Densitometric analysis of the data showed higher (P!0.01) intensity of GnRH I immunostaining in the brain of fish and amphibian as compared with reptile and bird. Intensity of GnRH I immunostaining in the ovary observed was significantly higher (P!0.01) in reptile and bird when compared with fish and amphibian. Western blot analysis for GnRH I-R in the ovary of the reptile showed higher (P!0.05) intensity of immunostaining when compared with the ovary of fish, amphibian, bird and the pituitary of rat. Values are significantly different with (a) fish, (b) amphibian, (c) reptile, (d) bird and (e) rat pituitary. 
